Introduction Validation strategy in biologics is changing as outsourcing, digital tools and new therapy types alter how companies prove process quality. Polaris Market Research reports that the bioprocess validation market size was valued at USD 520.28 million in 2025 and is projected to reach USD 1,129.97 million by 2034, exhibiting a CAGR of 9.0% during 2026–2034, with North America the...